This webinar is the first of Micropoint's educational series.  Topics will cover a spectrum of subjects to provide insight in the rapidly evolving healthcare in all parts of the globe.  


In this webinar, renowned cardiologist Dr. Alan Maisel discusses the evolution of how biomarkers continue to play a role in the management of heart failure patients. Dr. Maisel highlights the new drug Entresto (sacubatril/valsartan) and the challenges that high sensitivity troponins bring to patient assessment.  Case studies are presented to provide a better understanding and practical use of traditional biomarkers like the natriuretic peptides, but also with novel cardiac biomarkers like ST2.15



U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.